PATH | VRL
Menu

Protection From Routine Vaccination at the Age of 14 Months With Meningococcal Serogroup C Conjugate Vaccine in the Netherlands

This article, published in The Pediatric Infectious Disease Journal, reviews routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and a catch-up campaign, which has reduced the incidence of meningococcal C disease in the Netherlands, against routine vaccination in infancy only. In contrast to countries where routine vaccination is given in infancy, vaccine failures were not reported. This suggests that one dose of conjugated vaccine in the second year of life might offer longer lasting protection against meningococcal C disease than three doses in infancy. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A

Published: 2006

» Visit web page (English)

(Located at www.ncbi.nlm.nih.gov)

Citation: de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A. Protection From Routine Vaccination at the Age of 14 Months With Meningococcal Serogroup C Conjugate Vaccine in the Netherlands. The Pediatric Infectious Disease Journal. 2006;25(1):79-80.

Resource types: Peer-reviewed journal

Diseases/vaccines: Meningococcus

Topics: Disease/vaccine specific information

Regions: North America and Europe